p.43 抽出テキスト

August 1, 2017 Circulation. 2017;136:e60–e122. DOI: 10.1161/CIR.0000000000000499 e102

workshop on syncope risk stratification in the emergency department. Eur Heart J. 2016;37:1493–8. 121.	 Morag RM, Murdock LF, Khan ZA, et al. Do patients with a negative emergency department evaluation for syncope require hospital admission? J Emerg Med. 2004;27:339–43. 122.	 Shiyovich A, Munchak I, Zelingher J, et al. Admission for syncope: evaluation, cost and prognosis according to etiology. Isr Med Assoc J. 2008;10:104–8. 123.	 Schillinger M, Domanovits H, Müllner M, et al. Admission for syncope: evaluation, cost and prognosis. Wien Klin Wochenschr. 2000;112:835–41. 124.	 Chiu DT, Shapiro NI, Sun BC, et al. Are echocardiography, telemetry, ambulatory electrocardiography monitoring, and cardiac enzymes in emergency department patients presenting with syncope useful tests? A preliminary investigation. J Emerg Med. 2014;47:113–8. 125.	 Thiruganasambandamoorthy V, Ramaekers R, Rahman MO, et al. Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review. Intern Emerg Med. 2015;10:1003–14. 126.	 Pfister R, Diedrichs H, Larbig R, et al. NT-pro-BNP for differential diagnosis in patients with syncope. Int J Cardiol. 2009;133:51–4. 127.	 Reed MJ, Mills NL, Weir CJ. Sensitive troponin assay predicts outcome in syncope. Emerg Med J. 2012;29:1001–3. 128.	 Prandoni P, Lensing AWA, Prins MH, et al. Prevalence of pulmonary embolism among patients hospitalized for syncope. N Engl J Med. 2016;375:1524–31. 129.	 Tanimoto K, Yukiiri K, Mizushige K, et al. Usefulness of brain natriuretic peptide as a marker for separating cardiac and noncardiac causes of syncope. Am J Cardiol. 2004;93:228–30. 130.	 Costantino G, Solbiati M, Pisano G, et al. NT-pro-BNP for differential diagnosis in patients with syncope. Int J Cardiol. 2009;137:298–9; author reply 9. 131.	 Fedorowski A, Burri P, Juul-Moller S, et al. A dedicated investigation unit improves management of syncopal attacks (Syncope Study of Unselected Population in Malmo–SYSTEMA I). Europace. 2010;12:1322–8. 132.	 Kapoor WN. Evaluation and outcome of patients with syncope. Medicine (Baltimore). 1990;69:160–75. 133.	 Douglas PS, Garcia MJ, Haines DE, et al. ACCF/ASE/AHA/ASNC/HFSA/ HRS/SCAI/SCCM/SCCT/SCMR 2011 appropriate use criteria for echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Am Coll Cardiol. 2011;57:1126–66. 134.	 Probst MA, Kanzaria HK, Gbedemah M, et al. National trends in resource utilization associated with ED visits for syncope. Am J Emerg Med. 2015;33:998–1001. 135.	 Sparrow PJ, Merchant N, Provost YL, et al. CT and MR imaging findings in patients with acquired heart disease at risk for sudden cardiac death. Radiographics. 2009;29:805–23. 136.	 Sparrow P, Merchant N, Provost Y, et al. Cardiac MRI and CT features of inheritable and congenital conditions associated with sudden cardiac death. Eur Radiol. 2009;19:259–70. 137.	 Hulten EA, Carbonaro S, Petrillo SP, et al. Prognostic value of cardiac computed tomography angiography: a systematic review and meta- ­analysis. J Am Coll Cardiol. 2011;57:1237–47. 138.	 El Aidi H, Adams A, Moons KG.M, et al. Cardiac magnetic resonance imaging findings and the risk of cardiovascular events in patients with recent myocardial infarction or suspected or known coronary artery disease: a systematic review of prognostic studies. J Am Coll Cardiol. 2014;63:1031–45. 139.	 Tandri H, Calkins H. MR and CT imaging of arrhythmogenic cardiomyopathy. Card Electrophysiol Clin. 2011;3:269–80. 140.	 Steckman DA, Schneider PM, Schuller JL, et al. Utility of cardiac magnetic resonance imaging to differentiate cardiac sarcoidosis from arrhythmogenic right ventricular cardiomyopathy. Am J Cardiol. 2012;110:575–9. 141.	 Janardhanan R. Echocardiography in arrhythmogenic right ventricular dysplasia/cardiomyopathy: can the technology survive in the era of cardiac magnetic resonance imaging? Cardiol J. 2015;22:355–6. 142.	 Krumholz HM, Douglas PS, Goldman L, et al. Clinical utility of transthoracic two-dimensional and Doppler echocardiography. J Am Coll Cardiol. 1994;24:125–31. 143.	 Woelfel AK, Simpson RJ Jr, Gettes LS, et al. Exercise-induced distal atrio-

ventricular block. J Am Coll Cardiol. 1983;2:578–81. 144.	 Rozanski JJ, Castellanos A, Sheps D, et al. Paroxysmal second-degree

atrioventricular block induced by exercise. Heart Lung. 1980;9:887–90. 145.	 Oliveros RA, Seaworth J, Weiland FL, et al. Intermittent left anterior hemiblock during treadmill exercise test. Correlation with coronary arteriogram. Chest. 1977;72:492–4. 146.	 Bobba P, Salerno JA, Casari A. Transient left posterior hemiblock. Report of four cases induced by exercise test. Circulation. 1972;46:931–8. 147.	 Bharati S, Dhingra RC, Lev M, et al. Conduction system in a patient with Prinzmetal’s angina and transient atrioventricular block. Am J Cardiol. 1977;39:120–5. 148.	 Subbiah R, Chia PL, Gula LJ, et al. Cardiac monitoring in patients with syncope: making that elusive diagnosis. Curr Cardiol Rev. 2013;9:299–307. 149.	 Gibson TC, Heitzman MR. Diagnostic efficacy of 24-hour electrocardiographic monitoring for syncope. Am J Cardiol. 1984;53:1013–7. 150.	 Linzer M, Pritchett EL, Pontinen M, et al. Incremental diagnostic yield of loop electrocardiographic recorders in unexplained syncope. Am J Cardiol. 1990;66:214–9. 151.	 Linzer M, Yang EH, Estes NA 3rd, et al. Diagnosing syncope. Part 2: unexplained syncope. Clinical Efficacy Assessment Project of the American College of Physicians. Ann Intern Med. 1997;127:76–86. 152.	 Reiffel JA, Schwarzberg R, Murry M. Comparison of autotriggered memory loop recorders versus standard loop recorders versus 24-hour Holter monitors for arrhythmia detection. Am J Cardiol. 2005;95:1055–9. 153.	 Sivakumaran S, Krahn AD, Klein GJ, et al. A prospective randomized comparison of loop recorders versus Holter monitors in patients with syncope or presyncope. Am J Med. 2003;115:1–5. 154.	 Brown AP, Dawkins KD, Davies JG. Detection of arrhythmias: use of a patient-activated ambulatory electrocardiogram device with a solid-state memory loop. Br Heart J. 1987;58:251–3. 155.	 Cumbee SR, Pryor RE, Linzer M. Cardiac loop ECG recording: a new noninvasive diagnostic test in recurrent syncope. South Med J. 1990;83:39–43. 156.	 Locati ET, Moya A, Oliveira M, et al. External prolonged electrocardiogram monitoring in unexplained syncope and palpitations: results of the SYNARR-Flash study. Europace. 2016;18:1265–72. 157.	 Barrett PM, Komatireddy R, Haaser S, et al. Comparison of 24-hour Holter monitoring with 14-day novel adhesive patch electrocardiographic monitoring. Am J Med. 2014;127:95–7. 158.	 Rosenberg MA, Samuel M, Thosani A, et al. Use of a noninvasive continuous monitoring device in the management of atrial fibrillation: a pilot study. Pacing Clin Electrophysiol. 2013;36:328–33. 159.	 Turakhia MP, Hoang DD, Zimetbaum P, et al. Diagnostic utility of a novel leadless arrhythmia monitoring device. Am J Cardiol. 2013;112: 520–4. 160.	 Joshi AK, Kowey PR, Prystowsky EN, et al. First experience with a Mobile Cardiac Outpatient Telemetry (MCOT) system for the diagnosis and management of cardiac arrhythmia. Am J Cardiol. 2005;95:878–81. 161.	 Rothman SA, Laughlin JC, Seltzer J, et al. The diagnosis of cardiac arrhythmias: a prospective multi-center randomized study comparing mobile cardiac outpatient telemetry versus standard loop event monitoring. J Cardiovasc Electrophysiol. 2007;18:241–7. 162.	 Krahn AD, Klein GJ, Yee R, et al. Randomized assessment of syncope trial: conventional diagnostic testing versus a prolonged monitoring strategy. Circulation. 2001;104:46–51. 163.	 Krahn AD, Klein GJ, Yee R, et al. Cost implications of testing strategy in patients with syncope: randomized assessment of syncope trial. J Am Coll Cardiol. 2003;42:495–501. 164.	 Farwell DJ, Freemantle N, Sulke N. The clinical impact of implantable loop recorders in patients with syncope. Eur Heart J. 2006;27:351–6. 165.	 Da Costa A, Defaye P, Romeyer-Bouchard C, et al. Clinical impact of the implantable loop recorder in patients with isolated syncope, bundle branch block and negative workup: a randomized multicentre prospective study. Arch Cardiovasc Dis. 2013;106:146–54. 166.	 Krahn AD, Klein GJ, Norris C, et al. The etiology of syncope in patients with negative tilt table and electrophysiological testing. Circulation. 1995;92:1819–24. 167.	 Krahn AD, Klein GJ, Yee R, et al. Use of an extended monitoring strategy in patients with problematic syncope. Reveal Investigators. Circulation. 1999;99:406–10. 168.	 Moya A, Brignole M, Menozzi C, et al. Mechanism of syncope in patients with isolated syncope and in patients with tilt-positive syncope. Circulation. 2001;104:1261–7. 169.	 Brignole M, Menozzi C, Moya A, et al. Mechanism of syncope in pa-

tients with bundle branch block and negative electrophysiological test. Circulation. 2001;104:2045–50.

Downloaded from http://ahajournals.org by on October 7, 2026